UK HPA (Health Protection Agency) injects new impetus into needle safety debate
This article was originally published in Clinica
Executive Summary
Needle safety has again been thrust under the spotlight in the UK, with the publication of a report into the incidence of injuries associated with infections from HIV and from hepatitis B and C. More needs to be done to reduce the number of needlesticks, says the Health Protection Agency (HPA), citing its findings. The agency also wants to ensure that injured workers undergo the appropriate tests, in a timely manner, in order to receive preventive treatment.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.